Valentine Karen 4
4 · CONSTELLATION PHARMACEUTICALS INC · Filed Jan 20, 2021
Insider Transaction Report
Form 4
Valentine Karen
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2021-01-19$11.50/sh+17,203$197,835→ 17,203 total - Sale
Common Stock
2021-01-19$35.11/sh−7,203$252,889→ 0 total - Sale
Common Stock
2021-01-19$33.69/sh−1,227$41,342→ 7,203 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-19−17,203→ 81,939 totalExercise: $11.50Exp: 2028-07-18→ Common Stock (17,203 underlying) - Sale
Common Stock
2021-01-19$33.08/sh−8,773$290,232→ 8,430 total
Footnotes (5)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $32.51 to $33.505. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $33.56 to $33.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $35.00 to $35.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022.